Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2527439 | Clinical Therapeutics | 2012 | 17 Pages |
Abstract
FF/VI inhaled once daily in the morning for 28 days produced significant improvements in pulmonary function with a prolonged (>24 hours') duration of action in this population of patients with COPD. The combination was well tolerated. ClinicalTrials.gov identifier: NCT01072149.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Joseph A. MD, Krishna K. MD, Michael T. MS, MBA, Lisa MSc, Sarah K. PhD, Courtney MD,